How RWE can support drug development during COVID-19 and beyond
The COVID-19 pandemic introduced novel challenges for global biopharma organizations, as many...
The COVID-19 pandemic introduced novel challenges for global biopharma organizations, as many...
COVID-19 has heightened the need for an expanded understanding of clinical trial populations and...
The healthcare industry relies on real-world data more and more to make informed and effective...
December, 2020 - Philadelphia, PA - HealthVerity announced the most recent update to its...
November 24, 2020 - Philadelphia, PA - HealthVerity announced the most recent update to its...
Building a modern data infrastructure within today’s healthcare enterprise is challenging on many...
October 19, 2020 - Philadelphia, PA - HealthVerity announced the most recent update to its...
The “acceleration of digital health transformation” means many things to many people, but through...
“COVID-19 has impacted nearly every organization—from enterprise to startup—and their strategies...
September 17, 2020 - Philadelphia, PA - HealthVerity announced the biweekly update to its...
In just a few years, artificial intelligence (AI) has become a trusted tool in early drug discovery. Researchers using models like AlphaFold 3, RoseTTAFold All-Atom and others, can predict protein structures, design potential compounds and simulate d...